ArticleOpen forum infectious diseases2025

Patient-Reported Outcomes of Nirmatrelvir Treatment for High-Risk, Nonhospitalized Adults With Symptomatic COVID-19.

Wajeeha Ansari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.